Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
This report aims to provide a comprehensive presentation of the global market for Ischemic Stroke Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemic Stroke Drugs. This report contains market size and forecasts of Ischemic Stroke Drugs in global, including the following market information:
Global Ischemic Stroke Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ischemic Stroke Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
We surveyed the Ischemic Stroke Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ischemic Stroke Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ischemic Stroke Drugs Market Segment Percentages, by Type, 2022 (%)
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Others
Global Ischemic Stroke Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ischemic Stroke Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Ischemic Stroke Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ischemic Stroke Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ischemic Stroke Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ischemic Stroke Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
Daiichi Sankyo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ischemic Stroke Drugs, market overview.
Chapter 2: Global Ischemic Stroke Drugs market size in revenue.
Chapter 3: Detailed analysis of Ischemic Stroke Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ischemic Stroke Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ischemic Stroke Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ischemic Stroke Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ischemic Stroke Drugs Overall Market Size
2.1 Global Ischemic Stroke Drugs Market Size: 2022 VS 2029
2.2 Global Ischemic Stroke Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ischemic Stroke Drugs Players in Global Market
3.2 Top Global Ischemic Stroke Drugs Companies Ranked by Revenue
3.3 Global Ischemic Stroke Drugs Revenue by Companies
3.4 Top 3 and Top 5 Ischemic Stroke Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ischemic Stroke Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ischemic Stroke Drugs Players in Global Market
3.6.1 List of Global Tier 1 Ischemic Stroke Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Ischemic Stroke Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ischemic Stroke Drugs Market Size Markets, 2022 & 2029
4.1.2 Tissue Plasminogen Activator
4.1.3 Anticoagulant
4.1.4 Antiplatelet
4.1.5 Antihypertensive
4.1.6 Others
4.2 By Type - Global Ischemic Stroke Drugs Revenue & Forecasts
4.2.1 By Type - Global Ischemic Stroke Drugs Revenue, 2018-2023
4.2.2 By Type - Global Ischemic Stroke Drugs Revenue, 2024-2029
4.2.3 By Type - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ischemic Stroke Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Ischemic Stroke Drugs Revenue & Forecasts
5.2.1 By Application - Global Ischemic Stroke Drugs Revenue, 2018-2023
5.2.2 By Application - Global Ischemic Stroke Drugs Revenue, 2024-2029
5.2.3 By Application - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Ischemic Stroke Drugs Market Size, 2022 & 2029
6.2 By Region - Global Ischemic Stroke Drugs Revenue & Forecasts
6.2.1 By Region - Global Ischemic Stroke Drugs Revenue, 2018-2023
6.2.2 By Region - Global Ischemic Stroke Drugs Revenue, 2024-2029
6.2.3 By Region - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Ischemic Stroke Drugs Revenue, 2018-2029
6.3.2 US Ischemic Stroke Drugs Market Size, 2018-2029
6.3.3 Canada Ischemic Stroke Drugs Market Size, 2018-2029
6.3.4 Mexico Ischemic Stroke Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Ischemic Stroke Drugs Revenue, 2018-2029
6.4.2 Germany Ischemic Stroke Drugs Market Size, 2018-2029
6.4.3 France Ischemic Stroke Drugs Market Size, 2018-2029
6.4.4 U.K. Ischemic Stroke Drugs Market Size, 2018-2029
6.4.5 Italy Ischemic Stroke Drugs Market Size, 2018-2029
6.4.6 Russia Ischemic Stroke Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Ischemic Stroke Drugs Market Size, 2018-2029
6.4.8 Benelux Ischemic Stroke Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Ischemic Stroke Drugs Revenue, 2018-2029
6.5.2 China Ischemic Stroke Drugs Market Size, 2018-2029
6.5.3 Japan Ischemic Stroke Drugs Market Size, 2018-2029
6.5.4 South Korea Ischemic Stroke Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Ischemic Stroke Drugs Market Size, 2018-2029
6.5.6 India Ischemic Stroke Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Ischemic Stroke Drugs Revenue, 2018-2029
6.6.2 Brazil Ischemic Stroke Drugs Market Size, 2018-2029
6.6.3 Argentina Ischemic Stroke Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ischemic Stroke Drugs Revenue, 2018-2029
6.7.2 Turkey Ischemic Stroke Drugs Market Size, 2018-2029
6.7.3 Israel Ischemic Stroke Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Ischemic Stroke Drugs Market Size, 2018-2029
6.7.5 UAE Ischemic Stroke Drugs Market Size, 2018-2029
7 Ischemic Stroke Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Ischemic Stroke Drugs Major Product Offerings
7.1.4 Pfizer Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Ischemic Stroke Drugs Major Product Offerings
7.2.4 Merck Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Ischemic Stroke Drugs Major Product Offerings
7.3.4 Boehringer Ingelheim Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Ischemic Stroke Drugs Major Product Offerings
7.4.4 Sanofi Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Ischemic Stroke Drugs Major Product Offerings
7.5.4 Johnson & Johnson Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Ischemic Stroke Drugs Major Product Offerings
7.6.4 Bayer Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Ischemic Stroke Drugs Major Product Offerings
7.7.4 Biogen Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Ischemic Stroke Drugs Major Product Offerings
7.8.4 Abbott Laboratories Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Genentech
7.9.1 Genentech Company Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Ischemic Stroke Drugs Major Product Offerings
7.9.4 Genentech Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.9.5 Genentech Key News & Latest Developments
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Company Summary
7.10.2 Daiichi Sankyo Business Overview
7.10.3 Daiichi Sankyo Ischemic Stroke Drugs Major Product Offerings
7.10.4 Daiichi Sankyo Ischemic Stroke Drugs Revenue in Global Market (2018-2023)
7.10.5 Daiichi Sankyo Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ischemic Stroke Drugs Market Opportunities & Trends in Global Market
Table 2. Ischemic Stroke Drugs Market Drivers in Global Market
Table 3. Ischemic Stroke Drugs Market Restraints in Global Market
Table 4. Key Players of Ischemic Stroke Drugs in Global Market
Table 5. Top Ischemic Stroke Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ischemic Stroke Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ischemic Stroke Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ischemic Stroke Drugs Product Type
Table 9. List of Global Tier 1 Ischemic Stroke Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ischemic Stroke Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ischemic Stroke Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Ischemic Stroke Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ischemic Stroke Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Ischemic Stroke Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Ischemic Stroke Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ischemic Stroke Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Ischemic Stroke Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Ischemic Stroke Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ischemic Stroke Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ischemic Stroke Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ischemic Stroke Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ischemic Stroke Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ischemic Stroke Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ischemic Stroke Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Ischemic Stroke Drugs Product Offerings
Table 32. Pfizer Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Ischemic Stroke Drugs Product Offerings
Table 36. Merck Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Ischemic Stroke Drugs Product Offerings
Table 40. Boehringer Ingelheim Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Ischemic Stroke Drugs Product Offerings
Table 44. Sanofi Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Ischemic Stroke Drugs Product Offerings
Table 48. Johnson & Johnson Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Ischemic Stroke Drugs Product Offerings
Table 52. Bayer Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Biogen Company Summary
Table 55. Biogen Ischemic Stroke Drugs Product Offerings
Table 56. Biogen Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Biogen Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories Ischemic Stroke Drugs Product Offerings
Table 60. Abbott Laboratories Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Genentech Company Summary
Table 63. Genentech Ischemic Stroke Drugs Product Offerings
Table 64. Genentech Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Genentech Key News & Latest Developments
Table 66. Daiichi Sankyo Company Summary
Table 67. Daiichi Sankyo Ischemic Stroke Drugs Product Offerings
Table 68. Daiichi Sankyo Ischemic Stroke Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Daiichi Sankyo Key News & Latest Developments
List of Figures
Figure 1. Ischemic Stroke Drugs Segment by Type in 2022
Figure 2. Ischemic Stroke Drugs Segment by Application in 2022
Figure 3. Global Ischemic Stroke Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ischemic Stroke Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ischemic Stroke Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ischemic Stroke Drugs Revenue in 2022
Figure 8. By Type - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Ischemic Stroke Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Ischemic Stroke Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 16. US Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 28. China Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Ischemic Stroke Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Ischemic Stroke Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biogen Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Laboratories Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Genentech Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Daiichi Sankyo Ischemic Stroke Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
